Bruno Lomonte
#145,337
Most Influential Person Now
Researcher
Bruno Lomonte's AcademicInfluence.com Rankings
Bruno Lomontecomputer-science Degrees
Computer Science
#7241
World Rank
#7626
Historical Rank
Computational Linguistics
#1413
World Rank
#1429
Historical Rank
Machine Learning
#2615
World Rank
#2650
Historical Rank
Artificial Intelligence
#2907
World Rank
#2952
Historical Rank
Download Badge
Computer Science
Bruno Lomonte's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Bruno Lomonte Influential?
(Suggest an Edit or Addition)Bruno Lomonte's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phospholipase A2 myotoxins from Bothrops snake venoms. (1995) (538)
- Venoms, venomics, antivenomics (2009) (316)
- An overview of lysine-49 phospholipase A2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. (2003) (299)
- Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. (1993) (229)
- Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action (2008) (222)
- Medicinal plants with inhibitory properties against snake venoms. (2005) (219)
- A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). (1989) (211)
- Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America. (2010) (209)
- Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins. (2013) (205)
- Neutralizing interaction between heparins and myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. (1994) (202)
- Snake venomics and antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. (2009) (189)
- Myotoxin II from Bothrops asper (Terciopelo) venom is a lysine-49 phospholipase A2. (1991) (180)
- Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. (1998) (170)
- Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for Envenomation (2003) (170)
- Snake population venomics and antivenomics of Bothrops atrox: Paedomorphism along its transamazonian dispersal and implications of geographic venom variability on snakebite management. (2011) (170)
- Bactericidal activity of Lys49 and Asp49 myotoxic phospholipases A2 from Bothrops asper snake venom--synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. (1998) (169)
- Myotoxic phospholipases A(2) in bothrops snake venoms: effect of chemical modifications on the enzymatic and pharmacological properties of bothropstoxins from Bothrops jararacussu. (2000) (168)
- Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom. (2000) (158)
- Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Perú and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism. (2009) (156)
- Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in vitro. (1999) (146)
- Trends in snakebite envenomation therapy: scientific, technological and public health considerations. (2007) (140)
- Isolation, characterization and molecular cloning of AnMIP, a new alpha-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae). (2007) (135)
- The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. (1994) (134)
- Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii. (2008) (132)
- Snake venom Lys49 myotoxins: From phospholipases A(2) to non-enzymatic membrane disruptors. (2012) (130)
- Identification of the myotoxic site of the Lys49 phospholipase A(2) from Agkistrodon piscivorus piscivorus snake venom: synthetic C-terminal peptides from Lys49, but not from Asp49 myotoxins, exert membrane-damaging activities. (2001) (120)
- Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (Terciopelo) snake venom. (1995) (119)
- Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered from proteomic versus transcriptomic analysis. (2008) (118)
- Strategies in ‘snake venomics’ aiming at an integrative view of compositional, functional, and immunological characteristics of venoms (2017) (113)
- The effect of myotoxins isolated from Bothrops snake venoms on multilamellar liposomes: relationship to phospholipase A2, anticoagulant and myotoxic activities. (1991) (112)
- Antivenoms for snakebite envenomings. (2011) (110)
- Snake venomics of the Lesser Antillean pit vipers Bothrops caribbaeus and Bothrops lanceolatus: correlation with toxicological activities and immunoreactivity of a heterologous antivenom. (2008) (110)
- Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. (1986) (105)
- Structural and functional characterization of myotoxin I, a Lys49 phospholipase A(2) homologue from Bothrops moojeni (Caissaca) snake venom. (2000) (103)
- Profiling the venom gland transcriptomes of Costa Rican snakes by 454 pyrosequencing (2011) (100)
- Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. (2005) (100)
- Pros and cons of different therapeutic antibody formats for recombinant antivenom development (2018) (95)
- The phospholipase A2 homologues of snake venoms: biological activities and their possible adaptive roles. (2009) (95)
- Venomics of New World pit vipers: genus-wide comparisons of venom proteomes across Agkistrodon. (2014) (94)
- Venomic and antivenomic analyses of the Central American coral snake, Micrurus nigrocinctus (Elapidae). (2011) (93)
- Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. (2003) (93)
- ACUTE-PHASE REACTIONS, INCLUDING CYTOKINES, IN PATIENTS BITTEN BY BOTHROPS AND CROTALUS SNAKES IN BRAZIL (1995) (93)
- Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development. (2015) (92)
- From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy. (2016) (92)
- Inhibitory effects of Piper umbellatum and Piper peltatum extracts towards myotoxic phospholipases A2 from Bothrops snake venoms: isolation of 4-nerolidylcatechol as active principle. (2005) (91)
- Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead (2017) (88)
- Isolation and partial characterization of a myotoxin from the venom of the snake Bothrops nummifer. (1986) (87)
- Systemic and local myotoxicity induced by snake venom group II phospholipases A2: comparison between crotoxin, crotoxin B and a Lys49 PLA2 homologue. (2008) (87)
- Venoms of Micrurus coral snakes: Evolutionary trends in compositional patterns emerging from proteomic analyses. (2016) (86)
- Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica. (1989) (86)
- Venomous snakes of Costa Rica: biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics. (2014) (85)
- Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family. (1994) (85)
- Phospholipases A2 from viperidae snake venoms: how do they induce skeletal muscle damage? (2011) (84)
- Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom. (1994) (83)
- Snake venomics of Central American pitvipers: clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi. (2008) (81)
- Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment. (2005) (81)
- Comparative study of synthetic peptides corresponding to region 115-129 in Lys49 myotoxic phospholipases A2 from snake venoms. (2003) (79)
- Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper. (2009) (78)
- Isolation of an acidic phospholipase A2 from the venom of the snake Bothrops asper of Costa Rica: biochemical and toxicological characterization. (2010) (78)
- Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca. (2017) (78)
- Standardization of assays for testing the neutralizing ability of antivenoms. (1990) (77)
- Antimicrobial activity of myotoxic phospholipases A2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. (2005) (76)
- Proteomic and biological characterization of the venom of the redtail coral snake, Micrurus mipartitus (Elapidae), from Colombia and Costa Rica. (2011) (73)
- Isolation of basic myotoxins from Bothrops moojeni and Bothrops atrox snake venoms. (1990) (72)
- Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom. (1986) (69)
- Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A(2). (2005) (69)
- In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies (2018) (68)
- Intraspecies variation in the venom of the rattlesnake Crotalus simus from Mexico: different expression of crotoxin results in highly variable toxicity in the venoms of three subspecies. (2013) (68)
- Synergism between Basic Asp49 and Lys49 Phospholipase A2 Myotoxins of Viperid Snake Venom In Vitro and In Vivo (2014) (67)
- A structure-based proposal for a comprehensive myotoxic mechanism of phospholipase A2-like proteins from viperid snake venoms. (2014) (67)
- Isolation and biochemical, functional and structural characterization of a novel L-amino acid oxidase from Lachesis muta snake venom. (2012) (67)
- Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. (2014) (66)
- Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain (2010) (65)
- Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. (2001) (65)
- Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. (2000) (64)
- Snake venomics of Crotalus tigris: the minimalist toxin arsenal of the deadliest Nearctic rattlesnake venom. Evolutionary Clues for generating a pan-specific antivenom against crotalid type II venoms [corrected]. (2012) (64)
- Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps). (2016) (63)
- Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: contributions to understanding snakebite envenomings and their treatment. (2009) (63)
- Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score. (2015) (62)
- Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A(2). (2003) (60)
- Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of acceptors (2009) (60)
- Snake venomics of Micrurus alleni and Micrurus mosquitensis from the Caribbean region of Costa Rica reveals two divergent compositional patterns in New World elapids. (2015) (60)
- Biochemical characterization and pharmacological properties of a phospholipase A2 myotoxin inhibitor from the plasma of the snake Bothrops asper. (1997) (59)
- Local effects induced by coral snake venoms: evidence of myonecrosis after experimental inoculations of venoms from five species. (1983) (59)
- Neurotoxicity and other pharmacological activities of the snake venom phospholipase A2 OS2: the N-terminal region is more important than enzymatic activity. (2006) (59)
- Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms (2007) (59)
- Snake venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom toxins. (2015) (58)
- Snake venomics of Bothriechis nigroviridis reveals extreme variability among palm pitviper venoms: different evolutionary solutions for the same trophic purpose. (2010) (57)
- Skeletal muscle necrosis and regeneration after injection of Thalassophryne nattereri (niquim) fish venom in mice (2001) (57)
- Bactericidal and Antiendotoxic Properties of Short Cationic Peptides Derived from a Snake Venom Lys49 Phospholipase A2 (2005) (57)
- Assessing the preclinical efficacy of antivenoms: from the lethality neutralization assay to antivenomics. (2013) (56)
- Systemic cytokine response in children bitten by snakes in Costa Rica (2001) (54)
- Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties. (2000) (53)
- Activity of hemorrhagic metalloproteinase BaH-1 and myotoxin II from Bothrops asper snake venom on capillary endothelial cells in vitro. (1994) (52)
- Immunochemical characterization and role in toxic activities of region 115-129 of myotoxin II, a Lys49 phospholipase A2 from Bothrops asper snake venom. (1998) (52)
- Identification of residues critical for toxicity in Clostridium perfringens phospholipase C, the key toxin in gas gangrene. (2000) (51)
- Tyr-->Trp-substituted peptide 115-129 of a Lys49 phospholipase A(2) expresses enhanced membrane-damaging activities and reproduces its in vivo myotoxic effect. (1999) (51)
- Isolation and characterization of basic myotoxic phospholipases A2 from Bothrops godmani (Godman's pit viper) snake venom. (1992) (51)
- A Lys49 phospholipase A2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line (2005) (50)
- Synthetic peptides derived from the C-terminal region of Lys49 phospholipase A2 homologues from viperidae snake venoms: biomimetic activities and potential applications. (2010) (50)
- Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs. (2005) (49)
- Biological and biochemical activities of Vipera berus (European viper) venom. (1993) (49)
- Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms (2020) (49)
- Pathogenesis of myonecrosis induced by coral snake (Micrurus nigrocinctus) venom in mice. (1986) (49)
- Functional analysis of DM64, an antimyotoxic protein with immunoglobulin-like structure from Didelphis marsupialis serum. (2002) (48)
- An acidic phospholipase A₂ with antibacterial activity from Porthidium nasutum snake venom. (2012) (48)
- Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops atrox. (2004) (48)
- Innovative Immunization Strategies for Antivenom Development (2018) (47)
- Ontogenetic changes in the venom of the snake Lachesis muta stenophrys (bushmaster) from Costa Rica. (1990) (47)
- Acute physiopathological effects of honeybee (Apis mellifera) envenoming by subcutaneous route in a mouse model. (2010) (46)
- Structural and functional properties of BaTX, a new Lys49 phospholipase A2 homologue isolated from the venom of the snake Bothrops alternatus. (2007) (46)
- Purification and characterization of myotoxin IV, a phospholipase A2 variant, from Bothrops asper snake venom. (1995) (46)
- Hemostatic effects induced by Thalassophryne nattereri fish venom: a model of endothelium-mediated blood flow impairment. (2002) (45)
- Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper. (1992) (45)
- Venomic Analysis of the Poorly Studied Desert Coral Snake, Micrurus tschudii tschudii, Supports the 3FTx/PLA2 Dichotomy across Micrurus Venoms (2016) (45)
- Horse immunization with short-chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous species (2019) (45)
- Cytotoxicity induced in myotubes by a Lys49 phospholipase A2 homologue from the venom of the snake Bothrops asper: evidence of rapid plasma membrane damage and a dual role for extracellular calcium. (2007) (45)
- Snake venomics of the pit vipers Porthidium nasutum, Porthidium ophryomegas, and Cerrophidion godmani from Costa Rica: toxicological and taxonomical insights. (2012) (45)
- Effects of Bothrops asper Snake Venom on Lymphatic Vessels: Insights into a Hidden Aspect of Envenomation (2008) (44)
- Integrative characterization of the venom of the coral snake Micrurus dumerilii (Elapidae) from Colombia: Proteome, toxicity, and cross-neutralization by antivenom. (2016) (44)
- Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin. (1988) (44)
- Omics Meets Biology: Application to the Design and Preclinical Assessment of Antivenoms (2014) (44)
- Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. (1996) (43)
- Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom (2018) (42)
- Mipartoxin-I, a novel three-finger toxin, is the major neurotoxic component in the venom of the redtail coral snake Micrurus mipartitus (Elapidae). (2012) (42)
- Proteomic analysis of Bothrops pirajai snake venom and characterization of BpirMP, a new P-I metalloproteinase. (2013) (42)
- Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. (1997) (42)
- Tissue pathology induced by snake venoms: how to understand a complex pattern of alterations from a systems biology perspective? (2010) (41)
- Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved? (2014) (40)
- Danger in the reef: Proteome, toxicity, and neutralization of the venom of the olive sea snake, Aipysurus laevis. (2015) (40)
- Proteomic analysis of venom variability and ontogeny across the arboreal palm-pitvipers (genus Bothriechis). (2017) (40)
- Two color morphs of the pelagic yellow-bellied sea snake, Pelamis platura, from different locations of Costa Rica: snake venomics, toxicity, and neutralization by antivenom. (2014) (40)
- Neutralization of myotoxic phospholipases A2 from the venom of the snake Bothrops asper by monoclonal antibodies. (1992) (39)
- Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venoms (2005) (39)
- Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920) (2019) (39)
- A bright future for integrative venomics. (2015) (38)
- The venom of Bothrops asper from Guatemala: toxic activities and neutralization by antivenoms. (2001) (38)
- Myotoxic and cytolytic activities of dimeric Lys49 phospholipase A2 homologues are reduced, but not abolished, by a pH-induced dissociation. (2005) (38)
- Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom. (2011) (38)
- Cleavage of the NH2-terminal octapeptide of Bothrops asper myotoxic lysine-49 phospholipase A2 reduces its membrane-destabilizing effect. (1994) (38)
- Biological and Proteolytic Variation in the Venom of Crotalus scutulatus scutulatus from Mexico (2018) (37)
- Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A2 myotoxins – distinct mechanisms of action (2013) (37)
- Evaluation of the neutralizing ability of antivenoms for the treatment of snakebite envenomations in central America (1996) (37)
- Proteomic and functional analyses of the venom of Porthidium lansbergii lansbergii (Lansberg's hognose viper) from the Atlantic Department of Colombia. (2015) (36)
- Edema-forming activity of bushmaster (Lachesis muta stenophrys) and Central American rattlesnake (Crotalus durissus durissus) venoms and neutralization by a polyvalent antivenom. (1985) (36)
- Catalytically inactive phospholipase A2 homologue binds to vascular endothelial growth factor receptor-2 via a C-terminal loop region. (2008) (36)
- Proteomic and functional profiling of the venom of Bothrops ayerbei from Cauca, Colombia, reveals striking interspecific variation with Bothrops asper venom. (2014) (35)
- Cytotoxicity of Lachesis muta muta snake (bushmaster) venom and its purified basic phospholipase A2 (LmTX-I) in cultured cells. (2007) (35)
- Venom of the Coral Snake Micrurus clarki: Proteomic Profile, Toxicity, Immunological Cross-Neutralization, and Characterization of a Three-Finger Toxin (2016) (35)
- Host response toBothrops asper snake venom (1993) (35)
- Unresolved issues in the understanding of the pathogenesis of local tissue damage induced by snake venoms. (2018) (35)
- Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2 (2019) (35)
- An MTT-based method for the in vivo quantification of myotoxic activity of snake venoms and its neutralization by antibodies. (1993) (34)
- Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols. (2005) (34)
- Isolation of a galactose-binding lectin from the venom of the snake Bothrops godmani (Godmann's pit viper). (1990) (34)
- Fungicidal activity of a phospholipase-A2-derived synthetic peptide variant against Candida albicans. (2007) (34)
- Electrophoretic and immunochemical studies of Micrurus snake venoms. (1994) (34)
- Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice. (1996) (33)
- Structural characterization and phylogenetic relationships of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a Lys49 phospholipase A2 homologue (2002) (33)
- Isolation and characterization of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a new Lys49 phospholipase A2 homologue. (2000) (33)
- Isolation and characterization of a myotoxic phospholipase A2 from the venom of the arboreal snake Bothriechis (Bothrops) schlegelii from Costa Rica. (1997) (33)
- Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions. (2008) (33)
- Corrigendum: N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin (2016) (33)
- Histopathological and biochemical alterations induced by intramuscular injection of Bothrops asper (terciopelo) venom in mice. (1989) (33)
- Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129. (1999) (32)
- Intravascular hemolysis induced by the venom of the Eastern coral snake, Micrurus fulvius, in a mouse model: identification of directly hemolytic phospholipases A2. (2014) (32)
- The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes. (2010) (31)
- Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2 from the Central American coral snake, Micrurus nigrocinctus (2017) (31)
- Snake venomics and toxicological profiling of the arboreal pitviper Bothriechis supraciliaris from Costa Rica. (2012) (30)
- Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: Relationship to the neutralization of toxic and enzymatic activities (2010) (30)
- p-Bromophenacyl bromide modification of Bothrops asper myotoxin II, a lysine-49 phospholipase A2, affects its pharmacological activities. (1993) (30)
- High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays (2016) (29)
- Why myotoxin-containing snake venoms possess powerful nucleotidases? (2013) (29)
- South American snake venom proteins antigenically related to Bothrops asper myotoxins. (1990) (28)
- Effect of storage temperature on the stability of the liquid polyvalent antivenom produced in Costa Rica. (1990) (28)
- Protein-species quantitative venomics: looking through a crystal ball (2017) (28)
- Phospholipase A(2) enhances the endothelial cell detachment effect of a snake venom metalloproteinase in the absence of catalysis. (2015) (28)
- Antibody neutralization of a myotoxin from the venom of Bothrops asper (terciopelo). (1987) (28)
- A Lys49 Phospholipase A2, Isolated from Bothrops asper Snake Venom, Induces Lipid Droplet Formation in Macrophages Which Depends on Distinct Signaling Pathways and the C-Terminal Region (2012) (28)
- Envenomations by Bothrops and Crotalus Snakes Induce the Release of Mitochondrial Alarmins (2012) (28)
- An electrophoretic study on phospholipase A2 isoenzymes in the venoms of Central American crotaline snakes. (1992) (28)
- Quantitation by enzyme-immunoassay of antibodies against Bothrops myotoxins in four commercially-available antivenoms. (1991) (27)
- Critical Role of TLR2 and MyD88 for Functional Response of Macrophages to a Group IIA-Secreted Phospholipase A2 from Snake Venom (2014) (27)
- New insights into the phylogeographic distribution of the 3FTx/PLA2 venom dichotomy across genus Micrurus in South America. (2019) (27)
- Lemnitoxin, the major component of Micrurus lemniscatus coral snake venom, is a myotoxic and pro-inflammatory phospholipase A2. (2016) (27)
- Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A2 and mediates its toxic activity (2018) (26)
- Detection of proteins antigenically related to Bothrops asper myotoxin in crotaline snake venoms. (1987) (26)
- Unity Makes Strength: Exploring Intraspecies and Interspecies Toxin Synergism between Phospholipases A2 and Cytotoxins (2020) (24)
- Phospholipases a2 from Viperidae snakes: Differences in membranotropic activity between enzymatically active toxin and its inactive isoforms. (2015) (24)
- Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits. (2006) (24)
- Autocatalytic acylation of phospholipase-like myotoxins. (1995) (23)
- Mortality due to Hymenoptera stings in Costa Rica, 1985-2006. (2009) (23)
- Characterization of a basic phospholipase A2-homologeu myotoxin isolated from the venom of the snake Bothrops neuwiedii (yarará chica) from Argentina. (1999) (23)
- Proteomic and toxicological profiling of the venom of Bothrocophias campbelli, a pitviper species from Ecuador and Colombia. (2014) (21)
- An Asp49 Phospholipase A2 from Snake Venom Induces Cyclooxygenase-2 Expression and Prostaglandin E2 Production via Activation of NF-κB, p38MAPK, and PKC in Macrophages (2014) (21)
- Amino acid sequence and biological characterization of BlatPLA₂, a non-toxic acidic phospholipase A₂ from the venom of the arboreal snake Bothriechis lateralis from Costa Rica. (2013) (21)
- Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration. (2008) (21)
- Lys‐49‐phospholipases A2 as active enzyme for β‐arachidonoyl phospholipid bilayer membranes (1997) (21)
- Primary structures and partial toxicological characterization of two phospholipases A2 from Micrurus mipartitus and Micrurus dumerilii coral snake venoms. (2017) (20)
- First crotoxin-like phospholipase A(2) complex from a New World non-rattlesnake species: nigroviriditoxin, from the arboreal Neotropical snake Bothriechis nigroviridis. (2015) (20)
- Biological and Structural Characterization of Crotoxin and New Isoform of Crotoxin B PLA2 (F6a) from Crotalus durissus collilineatus Snake Venom (2007) (20)
- Isolation from a polyvalent antivenom of antibodies to a myotoxin in Bothrops asper snake venom. (1985) (20)
- Understanding structural and functional aspects of PII snake venom metalloproteinases: characterization of BlatH1, a hemorrhagic dimeric enzyme from the venom of Bothriechis lateralis. (2014) (20)
- Immunochemical properties of the N-terminal helix of myotoxin II, a lysine-49 phospholipase A(2) from Bothrops asper snake venom. (2001) (20)
- A Lys49-PLA2 myotoxin of Bothrops asper triggers a rapid death of macrophages that involves autocrine purinergic receptor signaling (2012) (19)
- Divergent functional profiles of acidic and basic phospholipases A2 in the venom of the snake Porthidium lansbergii lansbergii. (2016) (19)
- Mutual enlightenment: A toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance (2021) (18)
- Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. (1990) (18)
- Intravascular hemolysis induced by phospholipases A2 from the venom of the Eastern coral snake, Micrurus fulvius: Functional profiles of hemolytic and non-hemolytic isoforms. (2017) (18)
- Development of immunoassays for determination of circulating venom antigens during envenomations by coral snakes (Micrurus species). (1997) (18)
- Geographical variability of the venoms of four populations of Bothrops asper from Panama: Toxicological analysis and neutralization by a polyvalent antivenom (2017) (18)
- Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bothrops atrox Snake Venom (2020) (18)
- Venom variation in Bothrops asper lineages from north-western South America. (2020) (18)
- Immunochemical characterization of Micrurus nigrocinctus nigrocinctus venom with monoclonal and polyclonal antibodies. (1994) (18)
- Preclinical assessment of a polyspecific antivenom against the venoms of Cerrophidion sasai, Porthidium nasutum and Porthidium ophryomegas: Insights from combined antivenomics and neutralization assays. (2013) (18)
- Comparison of venom composition and biological activities of the subspecies Crotalus lepidus lepidus, Crotalus lepidus klauberi and Crotalus lepidus morulus from Mexico. (2013) (17)
- Comparative characterization of Viperidae snake venoms from Perú reveals two compositional patterns of phospholipase A2 expression (2020) (17)
- Crystal structure of a phospholipase A2 from Bothrops asper venom: Insights into a new putative "myotoxic cluster". (2017) (17)
- Identification of linear B-cell epitopes on myotoxin II, a Lys49 phospholipase A₂ homologue from Bothrops asper snake venom. (2012) (17)
- Isolation and characterization of four medium-size disintegrins from the venoms of Central American viperid snakes of the genera Atropoides, Bothrops, Cerrophidion and Crotalus. (2014) (16)
- Isolation of bothrasperin, a disintegrin with potent platelet aggregation inhibitory activity, from the venom of the snake Bothrops asper. (2003) (16)
- The synthetic Varespladib molecule is a multi-functional inhibitor for PLA2 and PLA2-like ophidic toxins. (2021) (16)
- Snake venomics of Bothrops punctatus, a semiarboreal pitviper species from Antioquia, Colombia (2014) (16)
- Effect of various Viperidae and Crotalidae snake venoms on endothelial cells in vitro. (1994) (16)
- Proteomic and toxinological characterization of the venom of the South African Ringhals cobra Hemachatus haemachatus. (2018) (16)
- Immunohistochemical demonstration of the binding of Bothrops asper myotoxin to skeletal muscle sarcolemma. (1987) (16)
- A catalytically-inactive snake venom Lys49 phospholipase A₂ homolog induces expression of cyclooxygenase-2 and production of prostaglandins through selected signaling pathways in macrophages. (2013) (15)
- Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping (2017) (15)
- Potent virucidal activity against Flaviviridae of a group IIA phospholipase A2 isolated from the venom of Bothrops asper. (2019) (14)
- Neutralization of coral snake Micrurus nigrocinctus venom by a monovalent antivenom. (1991) (14)
- Two phospholipase A 2 inhibitors from the plasma of Cerrophidion ( Bothrops ) godmani which selectively inhibit two different group-II phospholipase A 2 myotoxins from its own venom : isolation , molecular cloning and biological properties (14)
- Membrane cholesterol modulates the cytolytic mechanism of myotoxin II, a Lys49 phospholipase A2 homologue from the venom of Bothrops asper (2011) (13)
- Venom characterization of the three species of Ophryacus and proteomic profiling of O. sphenophrys unveils Sphenotoxin, a novel Crotoxin-like heterodimeric β-neurotoxin. (2019) (13)
- Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy (2020) (13)
- High‐density peptide microarray exploration of the antibody response in a rabbit immunized with a neurotoxic venom fraction (2017) (13)
- MipLAAO, a new L-amino acid oxidase from the redtail coral snake Micrurus mipartitus (2018) (13)
- Immunoenzymatic quantitation of antibodies to Bothrops asper myotoxins after polyvalent antivenom administration in mice. (1992) (12)
- A phospholipase A₂ from Bothrops asper snake venom activates neutrophils in culture: expression of cyclooxygenase-2 and PGE₂ biosynthesis. (2011) (12)
- A Secreted Phospholipase A2 Induces Formation of Smooth Muscle Foam Cells Which Transdifferentiate to Macrophage-Like State (2019) (12)
- First look into the venom of Roatan Island's critically endangered coral snake Micrurus ruatanus: Proteomic characterization, toxicity, immunorecognition and neutralization by an antivenom. (2019) (12)
- Neutralization of local effects of the terciopelo (Bothrops asper) venom by blood serum of the colubrid snake Clelia clelia. (1982) (11)
- Characterization of a novel snake venom component: Kazal-type inhibitor-like protein from the arboreal pitviper Bothriechis schlegelii. (2016) (11)
- A myotoxic Lys49 phospholipase A2‐homologue is the major component of the venom of Bothrops cotiara from Misiones, Argentina (2018) (11)
- In vivo treatment with varespladib, a phospholipase A2 inhibitor, prevents the peripheral neurotoxicity and systemic disorders induced by Micrurus corallinus (coral snake) venom in rats. (2021) (11)
- Venom characterization of the bark scorpion Centruroides edwardsii (Gervais 1843): Composition, biochemical activities and in vivo toxicity for potential prey. (2019) (11)
- 12-HETE is a regulator of PGE2 production via COX-2 expression induced by a snake venom group IIA phospholipase A2 in isolated peritoneal macrophages. (2019) (11)
- Physicochemical characterization of jicaro seeds (Crescentia alata H.B.K.): A novel protein and oleaginous seed (2017) (11)
- VENOM DIVERSITY IN THE NEOTROPICAL SCORPION GENUS TITYUS: IMPLICATIONS FOR ANTIVENOM DESIGN EMERGING FROM MOLECULAR AND IMMUNOCHEMICAL ANALYSES ACROSS ENDEMIC AREAS OF SCORPIONISM. (2020) (11)
- N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin (2016) (10)
- Danger in the canopy. Comparative proteomics and bioactivities of the venoms of the South American palm pitviper Bothrops bilineatus subspecies bilineatus and smaragdinus, and antivenomics of B. b. bilineatus (Rondônia) venom against the Brazilian pentabothropic antivenom. (2020) (10)
- Snake venomics, experimental toxic activities and clinical characteristics of human envenomation by Bothrocophias myersi (Serpentes: Viperidae) from Colombia. (2020) (10)
- Computational Biology in Costa Rica: The Role of a Small Country in the Global Context of Bioinformatics (2008) (10)
- An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity (2020) (10)
- Venom of the crotaline snake Atropoides nummifer (jumping viper) from Guatemala and Honduras: comparative toxicological characterization, isolation of a myotoxic phospholipase A(2) homologue and neutralization by two antivenoms. (2001) (10)
- Antivenomics: A Proteomics Tool for Studying the Immunoreactivity of Antivenoms (2015) (10)
- Novel Catalytically-Inactive PII Metalloproteinases from a Viperid Snake Venom with Substitutions in the Canonical Zinc-Binding Motif (2016) (10)
- Isolation of two basic phospholipases A2 from Bothrops diporus snake venom: Comparative characterization and synergism between Asp49 and Lys49 variants. (2019) (10)
- Snake Venom Phospholipase A2 Toxins (2021) (9)
- Functional, proteomic and transcriptomic characterization of the venom from Micrurus browni browni: Identification of the first lethal multimeric neurotoxin in coral snake venom. (2020) (9)
- A Lipidomic Perspective of the Action of Group IIA Secreted Phospholipase A2 on Human Monocytes: Lipid Droplet Biogenesis and Activation of Cytosolic Phospholipase A2α (2020) (9)
- Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms. (2021) (9)
- Ontogenetic changes in the venom of Metlapilcoatlus nummifer, the mexican jumping viper. (2020) (9)
- Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations. (2007) (9)
- A Lys49 phospholipase A(2) homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. (2005) (9)
- Homogenates of skeletal muscle injected with snake venom inhibit myogenic differentiation in cell culture (2013) (9)
- Structure of myotoxin II, a catalytically inactive Lys49 phospholipase A2 homologue from Atropoides nummifer venom. (2006) (9)
- Proteomic profiling, functional characterization, and immunoneutralization of the venom of Porthidium porrasi, a pitviper endemic to Costa Rica. (2019) (8)
- Solving the microheterogeneity of Bothrops asper myotoxin-II by high-resolution mass spectrometry: Insights into C-terminal region variability in Lys49-phospholipase A2 homologs. (2022) (8)
- Enzymatic labelling of snake venom phospholipase A2 toxins. (2019) (8)
- Pitfalls to avoid when using phage display for snake toxins (2017) (8)
- Biochemical characterization of the venom of Central American scorpion Didymocentrus krausi Francke, 1978 (Diplocentridae) and its toxic effects in vivo and in vitro. (2019) (8)
- In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom (2022) (8)
- Effect of calcineurin inhibitors on myotoxic activity of crotoxin and Bothrops asper phospholipase A2 myotoxins in vivo and in vitro. (2006) (8)
- N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils (2016) (8)
- A Representative GIIA Phospholipase A2 Activates Preadipocytes to Produce Inflammatory Mediators Implicated in Obesity Development (2020) (8)
- Cloning, purification and characterization of nigrelysin, a novel actinoporin from the sea anemone Anthopleura nigrescens. (2019) (7)
- Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect (2017) (7)
- Effects of a myotoxic phospholipase A2 isolated from Bothrops asper venom on skeletal muscle sarcoplasmic reticulum. (1987) (7)
- Venomics of the central American lyre snake Trimorphodon quadruplex (Colubridae: Smith, 1941) from Costa Rica. (2020) (7)
- Phospholipase A2 and inflammation. (1995) (7)
- [Proteolytic activity of snake venoms of Costa Rica on casein]. (1983) (6)
- Resurrexit, sicut dixit, alleluia. Snake venomics from a 26-year old polyacrylamide focusing gel. (2012) (6)
- Screening for target toxins of the antiophidic protein DM64 through a gel-based interactomics approach. (2017) (6)
- A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis (2018) (6)
- Venomics of the Duvernoy's gland secretion of the false coral snake Rhinobothryum bovallii (Andersson, 1916) and assessment of venom lethality towards synapsid and diapsid animal models. (2020) (6)
- A novel pentameric phospholipase A2 myotoxin (PophPLA2) from the venom of the pit viper Porthidium ophryomegas. (2018) (6)
- Novel three-finger toxins from Micrurus dumerilii and Micrurus mipartitus coral snake venoms: Phylogenetic relationships and characterization of Clarkitoxin-I-Mdum. (2019) (6)
- Comparison of biochemical and cytotoxic activities of extracts obtained from dorsal spines and caudal fin of adult and juvenile non‐native Caribbean lionfish (Pterois volitans/miles) (2017) (5)
- Snake venoms: from research to treatment (2012) (5)
- Antibodies to Helicobacter pylori in dyspeptic patients, asymptomatic adults, and children from Costa Rica (1995) (5)
- Structural characterization and phylogenetic relationships of myotoxin II from Atropoides (Bothrops) nummifer snake venom, a Lys49 phospholipase A(2) homologue. (2002) (5)
- A constant area monolayer method to assess optimal lipid packing for lipolysis tested with several secreted phospholipase A2. (2015) (5)
- Effect of a recombinant Lys49PLA2 myotoxin and Lys49PLA2-derived synthetic peptides from Agkistrodon species on membrane permeability to water. (2004) (5)
- Proteogenomic analysis of the Clostridium difficile exoproteome reveals a correlation between phylogenetic distribution and virulence potential. (2020) (5)
- Critical Role of TLR 2 and MyD 88 for Functional Response of Macrophages to a Group IIA-Secreted Phospholipase A 2 from Snake Venom (2014) (4)
- Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies (2018) (4)
- Immunological cross-recognition and neutralization studies of Micrurus mipartitus and Micrurus dumerilii venoms by two therapeutic equine antivenoms. (2020) (4)
- Proteomic and toxicological analysis of the venom of Micrurus yatesi and its neutralization by an antivenom (2022) (4)
- Editorial: Novel Immunotherapies Against Envenomings by Snakes and Other Venomous Animals (2020) (4)
- Cytotoxicity of snake venom Lys49 PLA2-like myotoxin on rat cardiomyocytes ex vivo does not involve a direct action on the contractile apparatus (2021) (4)
- Tissue Damage and Inflammation Induced by Snake Venoms (2014) (3)
- Serum Antibody Response to Polysaccharides in Children with Recurrent Respiratory Tract Infections (2001) (3)
- Crystallization of the Lys49 PLA2 homologue, myotoxin II, from the venom of Atropoides nummifer. (2004) (3)
- Cardiac effect induced by Crotalus durissus cascavella venom: morphofunctional evidence and mechanism of action. (2020) (3)
- Partial efficacy of a Brazilian coralsnake antivenom and varespladib in neutralizing distinct toxic effects induced by sublethal Micrurus dumerilii carinicauda envenoming in rats. (2022) (3)
- What's in a mass? (2021) (3)
- Structural basis of the myotoxic inhibition of the Bothrops pirajai PrTX-I by the synthetic varespladib. (2022) (2)
- Three-finger toxins from the venom of Micrurus tschudii tschudii (desert coral snake): Isolation and characterization of tschuditoxin-I. (2019) (2)
- Half a century of research on Bothrops asper venom variation: Biological and biomedical implications. (2022) (2)
- The earless monitor lizard Lanthanotus borneensis - A venomous animal? (2020) (2)
- [Changes in the electrophoretic pattern of the venom of the bushmaster (Lachesis muta stenophrys) stored under various conditions]. (1985) (2)
- Comparative analysis of membranotropic properties of various phospholipases A2 from venom of snakes of the family viperidae (2014) (2)
- PROTEOMIC STUDIES ON MICRURUS (CORAL SNAKES) VENOM REVEAL A DICHOTOMY OF PHENOTYPES (2018) (2)
- Molecular Architecture of the Antiophidic Protein DM64 and its Binding Specificity to Myotoxin II From Bothrops asper Venom (2022) (2)
- Genetic and toxinological divergence among populations of Tityus trivittatus Kraepelin, 1898 (Scorpiones: Buthidae) inhabiting Paraguay and Argentina (2020) (2)
- Localization of Myotoxin I and Myotoxin II from the venom of Bothrops asper in a murine model. (2021) (2)
- In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies (2018) (2)
- Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes (2023) (2)
- In vitro discovery and optimization of a human monoclonal antibody that neutralizes neurotoxicity and lethality of cobra snake venom (2021) (1)
- Depletion of Complement Enhances the Clearance of Brucella abortus in Mice (2018) (1)
- Comparative characterization and synergism between two basic phospholipases A2 from Bothrops diporus snake venom. (2020) (1)
- [The snake-eating capacity and the resistance to snake venoms of the Zopilota (Clelia clelia, colubridae) of Costa Rica]. (1982) (1)
- Ability of the phospholipase A2 inhibitor Varespladib to abrogate or delay lethality induced by neurotoxic snake venoms. (2020) (1)
- [Comparative study of venoms of newborn and adult rattlesnakes (Crotalus durissus durissus)]. (1983) (1)
- A highly nutritious native seed as an innovative food resource in Central America (2016) (1)
- Lys49 myotoxins: Emerging insights into their modes of action. (2020) (1)
- Present and Future of Snake Venom Proteomics Profiling (2021) (1)
- [The serum of newborn Clelia clelia (Serpentes: Colubridae) neutralizes the hemorrhagic action of Brothrops asper venom (Serpentes: Viperidae)]. (1990) (1)
- Stable production of recombinant SARS-CoV-2 receptor-binding domain in mammalian cells with co-expression of a fluorescent reporter and its validation as antigenic target for COVID-19 serology testing (2022) (1)
- Proteomic and toxicological characterization of the venoms of the most enigmatic group of rattlesnakes: The long-tailed rattlesnakes. (2022) (1)
- Lys49 myotoxins, secreted phospholipase A2-like proteins of viperid venoms: A comprehensive review. (2023) (1)
- MOLECULAR NEUTRALIZATION STUDIES ON MYOTOXIN II, A LYSINE-49 PHOSPHOLIPASE A2 FROM THE VENOM OF THE SNAKE Bothrops asper. (1997) (1)
- (Evaluation of neutralizing ability of four commercially available antivenoms against the venom of Bothrops asper from Costa Rica) (1995) (1)
- Venomics of the poorly studied hognosed pitvipers Porthidium arcosae and Porthidium volcanicum. (2021) (1)
- Dissociation of enzymatic and toxic activities by the use of antibodies. (1990) (1)
- Cell surface nucleolin interacts with and internalizes Bothrops asper Lys49 phospholipase A2 and mediates its toxic activity (2018) (1)
- In Vivo Neutralization of Myotoxin II, a Phospholipase A2 Homologue from Bothrops asper Venom, Using Peptides Discovered via Phage Display Technology (2022) (1)
- Corrigendum to Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: Contributions to understanding snakebite envenomings and their treatment published in Toxicon 54 (7), (2009), 1012-1028 (2010) (1)
- Discovery of Peptidic Anti-cobratoxins by Next Generation Phage Display (2015) (1)
- Discovery of a broadly-neutralizing human antibody that can rescue mice challenged with neurotoxin-rich snake venoms (2022) (1)
- [Scientific publications of Costa Rica in Science Citation Index bibliometric analysis of the period 1999-2001]. (2002) (1)
- Snake venomics of Central American species from the Atropoides and Bothriechis genera (2008) (0)
- 223. TLR2 and MyD88 Signaling are Required for Efficient Response of Macrophages to MT-III a Phospholipase A2 (PLA2) from Bothrops asper Snake Venom (2012) (0)
- Comparative analysis of membranotropic properties of various phospholipases A2 from venom of snakes of the family viperidae (2014) (0)
- Obituary of George V. Odell, 1926–2006 (2007) (0)
- 196. Synthetic Peptides from Viperid Phospholipase A2 Myotoxins: Small Structures with Diverse Biomimetic Actions (2012) (0)
- Characterization of Extracellular Vesicles Secreted by a Clinical Isolate of Naegleria fowleri and Identification of Immunogenic Components within Their Protein Cargo (2022) (0)
- Myotoxic Phospholipases A2 from Venoms of Crotalid Snakes: Properties, Actions, and Neutralization (2001) (0)
- Harnessing phage display technology for discovery of human IgGs targeting clinically relevant toxins from the venom of the Central American coral snake (Micrurus nigrocinctus) (2019) (0)
- Corrigendum to: "Venomics of the poorly studied hognosed pitvipers Porthidium arcosae and Porthidium volcanicum". (2021) (0)
- Cocktails of human monoclonal IgG antibodies capable of neutralizing dendrotoxin-mediated neurotoxicity of black mamba venom in vivo (2019) (0)
- NOTES Serum Antibody Response to Polysaccharides in Children with Recurrent Respiratory Tract Infections (2001) (0)
- EXPLORING THE BASIS OF THE (UNCOMMON) DIRECT HEMOLYSIS CAUSED BY PHOPHOLIPASE A2 OF MICRURUS FULVIUS VENOM (2018) (0)
- First Insights into the Venom Composition of Two Ecuadorian Coral Snakes (2022) (0)
- Discovery of peptidic anti-myotoxins (2016) (0)
- Distinct effects of radicicol on myotoxic activity of crotoxin and Bothrops asper phospholipase A2 myotoxins in vivo and in vitro (2011) (0)
- 210. Understanding the Preclinical Efficacy Profile of Antivenoms: From the Lethality Potency Assay to Antivenomics (2012) (0)
- 224. Snake Venomics of Crotalus tigris. Evolutionary Clues for Generating a Pan-Specific Antivenom Against Crotalid Type II Venoms (2012) (0)
- Nucleolin internalizes Bothrops asper Lys49 phospholipase A2 forming cell surface amyloid-like assemblies (2017) (0)
- Comparative biochemical study of the venoms of scorpions Tityus asthenes and Centruroides edwardsii from Costa Rica. (2020) (0)
- Serum immunoglobulin levels in Cabécar and Guaymí Indians in Southeastern Costa Rica. (1987) (0)
- Modeling Protein-Protein Interactions: a structural insight of myotoxin-antimyotoxin complex based on cross-linking data, resolved by mass spectrometry (2019) (0)
- Studies on the mechanism of action of myoloxins isolated from Bothrops snake venoms (1996) (0)
- High-throughput epitope profiling of snake venom toxins: unveiling the complexity of antigen-antibody interactions of antivenoms (2016) (0)
- Crystal structure of the myotoxin-II from Atropoides nummifer venom (2006) (0)
- Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A[sub]2[sub] from the Central American coral snake, [i]Micrurus nigrocinctus[i] (2016) (0)
- Discovery of cross-reactive and recyclable human monoclonal antibodies for new recombinant antivenoms. (2020) (0)
- Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 and type 1 diabetes (2023) (0)
- Proteomic analysis of the mandibular glands from the Chinese crocodile lizard, Shinisaurus crocodilurus - Another venomous lizard? (2023) (0)
- Venomics of the Scorpion Tityus ocelote (Scorpiones, Buthidae): Understanding Venom Evolution in the Subgenus Archaeotityus (2022) (0)
- Coral snakes venomic of clinical importance in Colombia (2019) (0)
- Chapter 7: Research methods (2015) (0)
- Venomics of the colubrid snake Trimorphodon quadruplex from Costa Rica. (2020) (0)
- Epitopic Profiling of Antibody Response against Neurotoxins from the Black Mamba ( Dendroaspis polylepis ) (2016) (0)
- Harnessing human monoclonal antibodies for neutralisation of dendrotoxins in a murine model (2019) (0)
- Monoclonal human IgGs capable of neutralizing elapid neurotoxins in vivo (2019) (0)
- Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies (2018) (0)
- High-throughput epitope identification for snakebite antivenom (2015) (0)
- The snake venom MT-III, a representative GIIA secreted phospholipase A2, triggers proinflammatory pathways in preadipocytes: new insights into the roles of this class of enzymes in obesity (2019) (0)
- Harnessing phage display technology for generating fully human IgG antibodies that neutralise elapid neurotoxins (2019) (0)
- Antibodies against a single fraction of Micrurus dumerilii venom neutralize the lethal effect of whole venom. (2022) (0)
- Bothrops moojenl MYotoxin-II: structure and function (1999) (0)
- Structural analysis of a myotoxin-antimyotoxin complex by cross-linking, mass spectrometry, and bioinformatics (2019) (0)
- Crystal structure of Bothrops asper myotoxin II complexed with the anti-trypanosomal drug suramin (2005) (0)
- N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting (2016) (0)
- Myotoxic and hemorrhagic effects of fractions obtained from the venom of lionfish (pterois volitans) in mice and identification of potentially toxic components. (2020) (0)
- The status of taxonomy and venom in sea snakes (2017) (0)
- Investigating Antivenom Function and Cross-Reactivity – a Study of Antibodies and Their Targets (2015) (0)
- A phospholipase A2 homologue increases the intracellular calcium concentration and induces spontaneous intracellular calcium transients and cell collapse in adult rat cardiomyocytes (2018) (0)
- Aggregation behavior of sodium 3-(octyloxy)-4-nitrobenzoate in aqueous solution (2018) (0)
- Recovery from the Neuroparalysis Caused by the Micrurus nigrocinctus Venom Is Accelerated by an Agonist of the CXCR4 Receptor (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruno Lomonte?
Bruno Lomonte is affiliated with the following schools:
